Basilea Pharmaceutica AG (SWX:BSLN)
53.60
+0.80 (1.52%)
Mar 10, 2026, 11:36 AM CET
Basilea Pharmaceutica AG Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 159.8 | 120.71 | 59.93 | 84.66 | 53.7 | Upgrade
|
| Short-Term Investments | - | - | - | - | 95 | Upgrade
|
| Cash & Short-Term Investments | 159.8 | 120.71 | 59.93 | 84.66 | 148.7 | Upgrade
|
| Cash Growth | 32.38% | 101.41% | -29.21% | -43.07% | -8.08% | Upgrade
|
| Accounts Receivable | 13.49 | 8.88 | 27.89 | 33.15 | 24.95 | Upgrade
|
| Other Receivables | 49.79 | 49.31 | 30.26 | 28.55 | 39.5 | Upgrade
|
| Receivables | 63.28 | 58.18 | 58.15 | 61.7 | 64.45 | Upgrade
|
| Inventory | 21.56 | 31.61 | 26.41 | 24.24 | 22.78 | Upgrade
|
| Restricted Cash | 2.54 | 3.85 | 4.39 | 1.91 | 1.25 | Upgrade
|
| Other Current Assets | 4.56 | 6.56 | 3.27 | 2.85 | 3.88 | Upgrade
|
| Total Current Assets | 251.73 | 220.91 | 152.15 | 175.36 | 241.07 | Upgrade
|
| Property, Plant & Equipment | 18.15 | 18.98 | 20.55 | 21.57 | 2.92 | Upgrade
|
| Other Intangible Assets | 0.37 | 0.37 | 0.55 | 0.58 | 0.63 | Upgrade
|
| Long-Term Deferred Tax Assets | 11.7 | 17.33 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.17 | 0.04 | 22.07 | 0.26 | Upgrade
|
| Total Assets | 282 | 257.76 | 173.29 | 220.85 | 247.27 | Upgrade
|
| Accounts Payable | 15.06 | 11.49 | 5.85 | 0.19 | 10.62 | Upgrade
|
| Accrued Expenses | 23.9 | 21.5 | 13.1 | 18.9 | 27.9 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 15.45 | 37.47 | 123.51 | Upgrade
|
| Current Portion of Leases | 2.06 | 2.06 | 2.06 | 1.99 | 0.9 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 0.5 | Upgrade
|
| Current Unearned Revenue | 1.57 | 1.62 | 1.23 | 1.23 | 1.23 | Upgrade
|
| Other Current Liabilities | 6.62 | 8.89 | 9.9 | 15.07 | 9.76 | Upgrade
|
| Total Current Liabilities | 49.22 | 45.56 | 47.59 | 74.85 | 174.41 | Upgrade
|
| Long-Term Debt | 75.44 | 95.91 | 95.46 | 131.36 | 94.54 | Upgrade
|
| Long-Term Leases | 11.72 | 13.7 | 15.64 | 16.32 | 0.01 | Upgrade
|
| Long-Term Unearned Revenue | 9.46 | 11.39 | 9.46 | 10.69 | 11.93 | Upgrade
|
| Pension & Post-Retirement Benefits | 8.23 | 10.21 | 15.15 | 8.34 | 24.99 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0 | -0 | - | Upgrade
|
| Total Liabilities | 154.06 | 176.77 | 183.29 | 241.56 | 305.87 | Upgrade
|
| Common Stock | 13.32 | 13.17 | 13.1 | 13.09 | 12.99 | Upgrade
|
| Additional Paid-In Capital | 1,052 | 1,048 | 1,042 | 1,037 | 1,030 | Upgrade
|
| Retained Earnings | -882.57 | -923.29 | -1,001 | -1,011 | -1,023 | Upgrade
|
| Treasury Stock | -51.28 | -51.7 | -54.01 | -56.07 | -56.56 | Upgrade
|
| Comprehensive Income & Other | -3.9 | -4.74 | -10.21 | -3.79 | -21.62 | Upgrade
|
| Shareholders' Equity | 127.94 | 81 | -10 | -20.72 | -58.61 | Upgrade
|
| Total Liabilities & Equity | 282 | 257.76 | 173.29 | 220.85 | 247.27 | Upgrade
|
| Total Debt | 89.22 | 111.67 | 128.61 | 187.14 | 218.96 | Upgrade
|
| Net Cash (Debt) | 70.58 | 9.04 | -68.67 | -102.48 | -70.26 | Upgrade
|
| Net Cash Growth | 680.74% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 5.16 | 0.65 | -5.66 | -8.58 | -6.01 | Upgrade
|
| Filing Date Shares Outstanding | 12.29 | 12.13 | 12 | 11.95 | 11.84 | Upgrade
|
| Total Common Shares Outstanding | 12.29 | 12.13 | 12 | 11.95 | 11.84 | Upgrade
|
| Working Capital | 202.52 | 175.35 | 104.55 | 100.51 | 66.66 | Upgrade
|
| Book Value Per Share | 10.41 | 6.68 | -0.83 | -1.73 | -4.95 | Upgrade
|
| Tangible Book Value | 127.57 | 80.63 | -10.55 | -21.29 | -59.24 | Upgrade
|
| Tangible Book Value Per Share | 10.38 | 6.65 | -0.88 | -1.78 | -5.00 | Upgrade
|
| Machinery | 14.85 | 13.61 | 12.86 | 12.98 | 16.62 | Upgrade
|
| Leasehold Improvements | 2 | 1.8 | 1.8 | 1.8 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.